Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Dr. Reddy's Laboratories, Inc.: Metoprolol Succinate ER Tablets Recalled for Foreign Medication Contamination

Agency Publication Date: May 9, 2018
Share:
Sign in to monitor this recall

Summary

Dr. Reddy's Laboratories is recalling 8,160 bottles of Metoprolol Succinate Extended-Release (100 mg), a medication used to treat high blood pressure and chest pain. This recall was initiated because a different medication, a single tablet of Clopidogrel 75 mg (a blood thinner), was discovered inside a 100-count bottle of the Metoprolol. Consumers should check their prescription bottles immediately to ensure the tablets match the description of the prescribed medication. If you have an affected bottle, contact your doctor or pharmacist to discuss your treatment and how to obtain a safe replacement.

Risk

The presence of a foreign tablet means a patient could accidentally ingest Clopidogrel (a blood thinner) instead of their intended blood pressure medication. This could lead to an unexpected risk of bleeding or a failure to properly manage the patient's heart condition.

What You Should Do

  1. Identify your medication by checking the label for Metoprolol Succinate Extended-Release Tablets, USP, 100 mg in 100-count bottles with NDC 55111-468-01.
  2. Check your bottle for Batch Number C706254 with an expiration date of 08/2019.
  3. Inspect the tablets inside the bottle; if you find any tablet that looks different from the others or if you are unsure, do not consume it.
  4. Contact your healthcare provider or pharmacist immediately to report the issue and seek guidance on continuing your treatment.
  5. Return any unused product from the affected batch to your pharmacy to receive a refund and a correct replacement.
  6. Contact Dr. Reddy's Laboratories, Inc. at their Princeton, NJ location for further instructions regarding this recall.
  7. For additional questions or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare provider consultation and pharmacy return.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: Metoprolol Succinate Extended-Release Tablets, USP, 100 mg (100 Tablets bottle)
Model:
NDC 55111-468-01
Lot Numbers:
C706254 (Exp 08/2019)
Date Ranges: Expiration Date: 08/2019

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 79980
Status: Resolved
Manufacturer: Dr. Reddy's Laboratories, Inc.
Sold By: pharmacies nationwide
Manufactured In: India, United States
Units Affected: 8160 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.